SYNERCID

This brand name is authorized in United States, South Africa

Active ingredients

The drug SYNERCID contains a combination of these active pharmaceutical ingredients (APIs):

1 Quinupristin
UNII 23OW28RS7P - QUINUPRISTIN
Read about Quinupristin
2 Dalfopristin
UNII R9M4FJE48E - DALFOPRISTIN
Read about Dalfopristin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SYNERCID Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01FG02 Quinupristin/dalfopristin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FG Streptogramins
Discover more medicines within J01FG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 61570-260
Country: ZA Health Products Regulatory Authority Identifier(s): 35/20.1.1/0006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.